Kolestyramin Alternova (Colestyramine)

Colestyramine is a non‑absorbable polymer that binds bile acids within the intestinal lumen, forming an insoluble complex that is excreted in the feces. This interruption of the enterohepatic circulation forces the liver to convert more cholesterol into new bile acids, thereby lowering serum LDL cholesterol. The reduced bile‑acid pool also diminishes systemic bile‑acid levels, which alleviates pruritus and bile‑acid induced diarrhea.

The appropriate dose of Kolestyramin Alternova is individualized by the prescribing healthcare professional based on the patient’s specific condition, laboratory results, and therapeutic goals. Dosage adjustments may be required according to response, tolerance, and any concurrent medications. Patients should follow the prescriber’s instructions and not modify the dose without medical advice.

Safety data for colestyramine in pregnancy and lactation are limited, and the product is classified with an unknown pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Kolestyramin Alternova. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details—including any temperature‑controlled requirements—and assists with import documentation.

Kolestyramin Alternova belongs to the bile‑acid sequestrant class, which lowers LDL cholesterol by binding bile acids rather than inhibiting synthesis like statins. It is often used when statins are contraindicated, not tolerated, or as an adjunct to achieve additional LDL reduction. Unlike statins, it does not affect hepatic cholesterol synthesis, but it may interfere with the absorption of other oral drugs and fat‑soluble vitamins.

Kolestyramin Alternova should be stored at temperatures below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat. Ensure the container is tightly closed to maintain product integrity throughout its shelf life.

The medication is taken orally, usually mixed with water or another suitable liquid as directed by the prescriber. It is important to follow the specific instructions regarding timing relative to other oral medications, as colestyramine can reduce their absorption. Patients should not chew or crush the product unless the formulation specifically permits it.

The most serious risks include severe constipation or intestinal obstruction, which may require medical intervention, and allergic reactions that can manifest as rash, swelling, or breathing difficulties. Additionally, prolonged use can lead to hypertriglyceridemia and deficiencies of fat‑soluble vitamins (A, D, E, K), potentially causing related clinical complications.

Kolestyramin Alternova should be avoided in individuals with known hypersensitivity to colestyramine or any component of the formulation. Patients with existing bowel obstruction, severe constipation, or a history of intestinal blockage should not use it without close medical supervision. Caution is also advised for those with uncontrolled hypertriglyceridemia, and it is generally not recommended during pregnancy or lactation unless clearly indicated by a physician.